John Hlavaty ([email protected])
Mon, 30 Nov 1998 11:07:23 -0500
U.S.:
"Best Of + B-Sides":
#2-5-21
"Best Of":
#57-45
"The Sweetest Thing":
Reached #11 on Modern Rock charts last week. It
remains at #11 this week (7 total weeks on the chart, last
four weeks: #17-13-11-11).
"Best Of" Combined Sales (based on known sales figures and estimates
made from chart positions):
237,400 + 136,000 + 29,000 + ~50-65,000 + ~30-35,000 =
482,400-502,400
U.K.:
"Best Of + B-Sides":
#1-2-15-21
"Best Of":
#8-9-4
"The Sweetest Thing":
#3-4-10-18-31-38
Canada:
"Best Of + B-Sides":
#1-4
"Best Of":
#5
"The Sweetest Thing":
Part 1:
#1-3-3-3
Part 2:
#3-4-2-7
"Best Of" Combined Sales:
86,210 + 24,241 + 20,650 = 131,101
Ireland:
"Best Of":
#1-1
"The Sweetest Thing":
#1-2-4-9
Australia:
"Best Of":
#1-1-1
"The Sweetest Thing":
#6-6-10-10-15
One point of interest: In countries where the "Best Of + B-Sides"
charted separately from the "Best Of" without the b-side disk,
as the "Best Of + B-Sides" falls on the charts (due to its limited
availability), the "Best Of" without the b-side disk has continued
to rise or perform strongly on the charts. This suggests
that the combined performance of U2's "Best Of" will sell
well around the world.
Ciao,
John
John J. Hlavaty, Ph.D. Tel: 978-927-5054, ext. 360
New England BioLabs, Inc. Fax: 978-921-1350
32 Tozer Road e-mail: [email protected]
Beverly, Ma 01915
This archive was generated by hypermail 2.0b2 on Mon Nov 30 1998 - 08:14:24 PST